Check out your Company Bowl for anonymous work chats.
Final call – only two weeks left to apply for the LifeScienceXplained | Sartorius Award for New Communication 2024. Do you have a promising life science story and have not submitted it yet? Then go for it! Whether it's a blog, video, podcast, slam or other innovative format 🎥🎙️🖋️ – we're looking for creative minds who can explain the complex world of life sciences in a simple and exciting way. New: In addition to German-language entries, English-language contributions are now possible. The jury will select the top 3 entries for the award ceremony on November 7. Take your chance to win €15,000 with your creativity and explaining skills. ⏰ Submit your entry by August 4, 2024: www.sartorius.com/lsx
Sartorius closed the first half of the year with a positive trend in sales revenue development. Due to the ongoing high volatility and limited predictability, however, the company is now de-risking its outlook for the second half of the year. "Sartorius met its targets for the first half of the year, and we achieved the intended slight sales revenue growth and robust profitability in the second quarter. As in the first three months, the picture remained exceptionally mixed," said CEO Joachim Kreuzburg. "In the medium and long term, the mega topics of hashtag#healthcare and hashtag#biotechnology remain strong structural drivers for our profitable growth strategy, and the increased volatility caused by the pandemic has not made any difference to this.” ➡️ Moderately positive revenue development in Q2 ➡️ Demand recovery remains muted ➡️ Full-year outlook deliberately more cautious ➡️ Long-term trends in life sciences & biopharma remain positive Read media release: https://lnkd.in/emm-3rNs
Transforming water use in filter production: Potential to save over 50 million liters annually. Filter production demands significant amounts of purified water. Ghiath Wahbi, Project Manager for Separation Technologies, and his team introduced a prototype for a water recycling system for filter production, enabling the reuse of the vital resource. This invention can not only conserve water but also reduce energy costs and carbon emissions. Discover more about this innovative project on the Sartorius blog: https://ow.ly/pq4v50SwSVC
Heart failure affects an estimated 40 to 60 million individuals globally. Find out how Sartorius and the biotech company Repairon are hashtag#InThisTogether for a cure Shortly after birth, our heart muscle cells lose their ability to divide. This means that damage such as a heart attack leads to an irreversible loss of these cells. As a result, the heart's ability to pump effectively decreases, which can lead to heart failure. For over two decades, the team at Repairon has been researching to develop the so-called heart patch. This new heart tissue is artificially grown from stem cells in the lab and then sewn onto special membranes compatible with the human body. Discover how Sartorius supports Repairon in the production of stem cells for heart patches on the Sartorius Blog: https://ow.ly/gPXZ50Svinq
Recapping Pride Month!🌈 As June, dedicated to celebrating the LGBTQ+ community, comes to an end, we would like to spotlight the activities that employee resource groups at Sartorius organized and hosted. Highlights of this year’s Pride Month: - Participation in the Long Island Pride Parade - Pride Celebration and Employee Appreciation Party - Virtual Panel Discussion with participants from Sartorius’ sites around the world All events had one goal: to focus on the LGBTQ+ community, raise awareness of their challenges, and promote a culture of diversity, equity, belonging, and inclusion within the company. Read more about the events on the Sartorius blog: https://sar.to/njtvo
Have you ever heard of the mosquito-borne chikungunya virus? According to the WHO, more than two million cases of chikungunya infections, which cause flu-like symptoms and severe joint pain, have been reported since 2005. No vaccine was available against the virus – until Sartorius’ customer Valneva had their vaccine approved by the FDA in late 2023. Learn more on the Sartorius blog about how we are part of the solution and how recombinant albumin from Albumedix now a part of Sartorius, stabilizes the vaccine during storage and transport: https://sar.to/voytu
Is time of the essence? The clocks are ticking louder for scientists and engineers researching new treatments for cancer, genetic disorders, and the pandemics of tomorrow. Moving quickly from discovering to delivering biological therapeutics can make or break its success. Sartorius’ single-use technologies are a speed boost, cutting production time and costs, while enhancing flexibility. This empowers research teams around the world to simplify and accelerate progress in life science and bioprocessing. We’re in this together. Expedite your drug to market through rapid deployment of single-use solutions. Discover our scalable single-use technologies at www.sartorius.com
Striving towards making a positive impact on UN sustainability goal number 3 – health and well-being? Scientists worldwide are tirelessly working to discover new solutions against cancer, inheritable diseases, and future pandemics. Sartorius supports them with cutting-edge technologies that help translate scientific discoveries into effective therapies more quickly. So that patients get the treatments they need. In doing so, together, we are making an impact to “health and well-being”. We're in this together. Our innovations enable you to provide more people with access to better healthcare. Let's join forces and improve social sustainability and more at www.sartorius.com
Construction completed in Ann Arbor! Two years after breaking ground in the Tech Loop at Research Park, Sartorius today celebrates the opening of its new Center of Excellence for Bioanalytics in Ann Arbor, Hashtag#Michigan, USA. The 130,000-square-foot facility houses a modern manufacturing and services area, biology labs, a warehouse, office and training spaces, as well as a Customer Interaction Center (CIC). It was built with a focus on sustainability. "Sartorius is a leading provider of highly automated bioanalytical solutions that are used in the discovery and development of innovative biopharmaceutical drugs. With our new flagship site in Ann Arbor, we are bringing together our core competencies and dedicated experts under one roof, further strengthening our ability to address key customer needs in this highly innovative and relevant field," said Dr. Alexandra Gatzemeyer, Head of the Lab Products & Services division and member of the Executive Board of Sartorius. Read media release: https://sar.to/pi1xz
Are you eager to turn your career goals into reality and explore new opportunities? This is your chance. Explore our current job openings at www.sartorius.com/careers and find your perfect match in Sales, Services, Research and Development and other teams. Ready to apply? Here's what to do: ➔ Go to www.sartorius.com/careers ➔ Pick the position that matches your ambitions and qualifications ➔ Hit 'Apply Now' and complete the application form
